GoodRx Balance Sheet
NASDAQ: GDRXTechnologyEDP ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GoodRx financial position
At the end of fiscal 2025, GoodRx reported total assets of $1.40 billion, up 1.2% from a year earlier against total liabilities of $787.8 million. Shareholders' equity stood at $616.3 million, or 43.9% of assets. The company held $261.8 million in cash and equivalents against $488.3 million of debt, a net debt position of $226.4 million.
The current ratio (current assets divided by current liabilities) was 2.61, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.79.
Summary generated from market data by MetaCap's automated system. Methodology
GoodRx balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 261.82M | 448.35M | 672.30M | 757.16M | 941.11M | 968.69M | 26.05M | 34.60M |
| Receivables | 235.75M | 145.93M | 143.61M | 117.14M | 118.08M | 68.73M | 48.13M | — |
| Total Current Assets | 643.10M | 659.25M | 872.79M | 919.69M | 1.09B | 1.09B | 86.58M | — |
| Property, Plant & Equipment | 12.27M | 12.66M | 15.93M | 19.82M | 21.61M | 23.06M | 1.86M | — |
| Goodwill | 430.33M | 410.77M | 410.77M | 412.12M | 329.70M | 261.12M | 236.22M | 220.42M |
| Intangible Assets | 64.08M | 52.10M | 60.90M | 119.86M | 88.79M | 36.92M | 21.27M | — |
| Total Assets | 1.40B | 1.39B | 1.59B | 1.60B | 1.61B | 1.47B | 386.80M | — |
| Accounts Payable | 19.41M | 14.14M | 36.27M | 17.70M | 17.50M | 10.29M | 7.85M | — |
| Short-Term Debt | 5.00M | 5.00M | 8.79M | 7.03M | 7.03M | 7.03M | 7.03M | — |
| Total Current Liabilities | 246.00M | 123.90M | 122.56M | 76.32M | 81.11M | 59.55M | 33.37M | — |
| Long-Term Debt | 483.26M | 486.71M | 647.70M | 651.80M | 655.86M | 659.89M | 663.89M | — |
| Total Liabilities | 787.80M | 663.41M | 826.84M | 789.80M | 775.95M | 758.75M | 737.37M | — |
| Shareholders' Equity | 616.26M | 724.66M | 761.96M | 814.83M | 831.68M | 711.36M | -1.09B | -1.16B |
| Retained Earnings | -1.41B | -1.44B | -1.46B | -1.45B | -1.42B | -1.39B | -1.10B | — |
| Total Debt | 488.26M | 491.71M | 656.49M | 658.83M | 662.89M | 666.92M | 670.92M | — |
| Net Cash (Debt) | -226.44M | -43.37M | 15.81M | 98.34M | 278.22M | 301.77M | -644.87M | 34.60M |
This table shows 8 annual periods of GoodRx's balance sheet, from FY 2025 back to FY 2018, across 16 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow GDRX's reporting calendar. What is a balance sheet?